eli lilly glp 1 agonist to seek approval of new GLP-1 weight-loss drug this year What's Coming Next for GLP-1
Description
Wegovy is injected under the skin once a week

Both the 2016 consensus statement of the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) on management of type 2 diabetes and the 2016 American Diabetes Association (ADA) standards recommend adding on GLP-1 RAs to patients not meeting treatment goals with basal insulin

generated a novel family of non-covalent, benzimidazole-based DPP-4 inhibitors from a small fragment hit (110)
Patterson D, Abell T, Rothstein R, et al

Cytokine (2000) 12(7):113641

[DOI] [PubMed] [Google Scholar] 117.Ritz-Laser B., Estreicher A., Klages N., Saule S., Philippe J
